The Health Research Council of New Zealand, Te Aho o Te Kahu – the Cancer Control Agency, and the Ministry of Health (‘the funding partners’) are pleased to announce the opening today of funding applications for high-quality research that will drive equitable cancer outcomes for New Zealanders.
The funding partners invite research proposals that address one or more of the following equity-centred cancer research priorities:
1. Lung cancer screening
2. Clinical lung cancer research
3. Innovative approaches to delivering cancer care
4. Patient experience across the cancer journey for Māori and Pacific peoples.
A total funding pool of $6.2 million (exclusive of GST) is available for research across all four research priorities. The funding partners expect to fund a portfolio of research projects at a range of values within this funding pool.
Applicants are invited to apply for funding within two funding streams:
• Stream 1. Lung cancer screening – $1.94 million available for one or more research projects addressing priority 1
• Stream 2. Improving clinical cancer care – $4.26 million available for approximately four to eight research projects addressing priorities 2, 3 and/or 4.
Applicants will need to outline how their proposal addresses the RFP requirements and provide a clear justification for the proposed approach along with a description of the team’s ability to deliver the specific components of the research.
It is anticipated the contracted projects will begin as soon as practicable, with funding available for an immediate start following notification of outcomes between November and December 2021.
The development of this RFP has been informed by the recently released He Pūrongo Mate Pukupuku o Aotearoa 2020, State of Cancer in New Zealand 2020 report. This report provides a snapshot of cancer care in New Zealand, and in particular highlights the inequities faced by Māori, Pacific peoples and other communities that experience disparities in cancer outcomes.
